Systems Biomedicine and Precision Therapeutics

The Systems Biomedicine Programme at FIMM focuses on gaining fundamental, novel understanding on cancers. The cancer types studied include both haematological malignancies and solid tumours, such as lung, ovarian, prostate, renal and pancreatic cancers. The overall objective of the programme is not only to investigate molecular mechanisms of cancer but also to discover novel personalised therapeutic strategies.

Researchers in this area develop high throughput screening technologies and bioinformatics tools for system-level data analysis. Two of the groups are specialised in developing biostatistical and machine learning models and applying these to biomedical questions. Two groups focus on developing automated image analysis technologies and image based diagnostics. These tools enable the combination of data produced by screening with similar system-level information from other resources to discover disease mechanisms.

All of the Systems Biomedicine research groups significantly contribute to the “Individualised Systems Medicine in Cancer” and “Digital Diagnostics for Precision Medicine” Grand Challenges.

You can learn more about the Principal Investigators and their research groups and projects in Systems Biomedicine by clicking the turning boxes below. In addition, several FIMM Senior Researchers have their own research projects.

Last updated: 05.11.2018 - 15:06